Remove Genetic Engineering Remove Licensing Remove Protein Remove Recombinant Antibody
article thumbnail

What to expect from PEGS Europe 2023: Day 2

Drug Discovery World

Ahead of protein and antibody engineering conference PEGS Europe 2024 in Lisbon, DDW’s Megan Thomas looks at what to expect from each track of the annual biologics technology meeting. These include: Xiaole Shirley Liu, PhD, CEO, GV20 Therapeutics, on: ‘AI-based target and antibody discovery from patient tumour profiles’.